Arcuro Medical

Meniscus Repair System

Health Tech & Life Sciences
Active
Series A Founded 2013
Total raised
$670K
Last: Series A 2025-01
Stage
Series A
Founded
2013
Headcount
10
HQ
Sector
Health Tech & Life Sciences

About

Arcuro Medical has developed a meniscus repair system that allows the entire procedure to be performed inside the joint space, using suture material only and requiring a single entry into the joint. Arcuro's proprietary SuperBall repair system consists of an all-suture, knotless anchor and delivery system for safe, reliable, and effective meniscus repair. In May 2020, the company received a CE Mark for its SuperBall meniscus repair system. This will permit the commercialization of Arcuro's meniscal repair technology throughout the European Union, in conjunction with additional markets including the United States (where the system has already received FDA clearance and is patented).

Funding history · 3 rounds · $670K total

2025-01
Series A Undisclosed
2016-04
Seed $670K
Date unknown
Undisclosed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Arcuro Medical's primary product?
Arcuro Medical's primary product is the SuperBall meniscus repair system, which allows for meniscus repair entirely within the joint space using an all-suture, knotless anchor and delivery system.
When was Arcuro Medical founded?
Arcuro Medical was founded in December 2013.
When did Arcuro Medical receive FDA clearance for its SuperBall system?
Arcuro Medical received FDA regulatory clearance for its SuperBall meniscus repair system in June 2018.
When did Arcuro Medical receive CE Mark for its SuperBall system?
In May 2020, Arcuro Medical received a CE Mark for its SuperBall meniscus repair system, enabling commercialization in the European Union.
Which markets does Arcuro Medical target for its products?
Arcuro Medical targets geographic markets including the United States, South America, Europe, and China.
When did Arcuro Medical close its Series A financing round?
Arcuro Medical closed its Series A financing round in January 2025, with Varana Capital and Consensus Business Group (CBG) among the investors.
What was a significant product expansion announced by Arcuro Medical in February 2026?
In February 2026, Arcuro Medical announced the launch of its new SuperBall-RC (Rotator Cuff Repair System) and an enhanced meniscus repair system, significantly expanding its market opportunity.
How many employees does Arcuro Medical currently have?
Arcuro Medical currently has 10 employees.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Commerce & RetailDistribution ChannelsDistributorHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

orthopedicsmedical-devicesregenerative-medicinesurgerydoctorssurgeonsathletesclinicshealthcare-providershospitalstreatments